5 results
6-K
EX-99.2
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
anifrolumab (Saphnelo®) (anti-IFN) from Astra Zeneca. There are currently over 10 products in Phase 3 for SLE, of which the minority are oral
S-8
EX-99.1
GLPG
Galapagos NV
24 May 19
Registration of securities for employees
5:16pm
are listed or traded on a regulated market at the date of the Offer and the Beneficiaries not only consist of Employees but also include (as a minority … this Plan are in majority reserved for and granted to Employees. The number of Beneficiaries consists in minority of Directors and a Consultant
S-8
EX-99.1
GLPG
Galapagos NV
29 May 18
Registration of securities for employees
5:01pm
not only consist of Employees but also include (as a minority) a Consultant and Directors, the Exercise Price will at least be equal to the average … consists in minority of Directors and a Consultant and in majority of Employees.
Acceptance or Refusal of the Offer
The Beneficiaries have
DRS
EX-10
GLPG
Galapagos NV
6 Feb 15
Draft registration statement
12:00am
for and granted to Employees. The Board of Directors will ensure that a minority of the number of Beneficiaries will consist of Directors and Consultants … to Employees. The Directors will ensure that a minority of the number of Beneficiaries will consist of Directors and a majority will consist of Employees
- Prev
- 1
- Next